Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin

European Cells and Materials

Volumn 24, Issue , 2012, Pages 197-210

  Jahn K ^a   Lara Castillo, N ^a   Brotto, L ^a   Mo, C L ^a   Johnson, M L ^a   Brotto, M ^a,b   Bonewald, Lynda F ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Apoptosis; Bone; Glucocorticoid; Osteocytes; catenin

Indexed keywords

BETA CATENIN; MUSCLE PROTEIN; MYOKINE; UNCLASSIFIED DRUG; WNT PROTEIN; DEXAMETHASONE; GLUCOCORTICOID; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN 3T3; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROSTIMULATION; MALE; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; OSTEOCYTE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; METABOLISM; OSTEOBLAST; PHYSIOLOGY; SECRETION (PROCESS); WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; BETA CATENIN; CELL LINE; CULTURE MEDIA, CONDITIONED; DEXAMETHASONE; GLUCOCORTICOIDS; MICE; MUSCLE, SKELETAL; OSTEOBLASTS; OSTEOCYTES; RNA, SMALL INTERFERING; WNT SIGNALING PATHWAY;

EID: 84869213519     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v024a14     Document Type: Article

References (66)

1. Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF (2003) CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144: 1761-1769.
2. Barclay CJ (2005) Modelling diffusive O(2) supply to isolated preparations of mammalian skeletal and cardiac muscle. J Muscle Res Cell Motil 26: 225-235.
3. Beno T, Yoon YJ, Cowin SC, Fritton SP (2006) Estimation of bone permeability using accurate microstructural measurements. J Biomech 39: 2378-2387.
4. Bonewald LF (2007a) Osteocytes. In: Osteoporosis (R. Marcus, D. Feldman, D. Nelson, C. Rosen, eds), Elsevier, Amsterdam, pp 169-190.
5. Bonewald LF (2007b) Osteocytes as dynamic, multifunctional cells. Ann N Y Acad Sci 1116: 281-290.
6. Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 26: 229-238.
7. Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42: 606-615.
8. Brotto MA, Andreatta-van Leyen S, Nosek CM, Brotto LS, Nosek TM (2000) Hypoxia and fatigue-induced modification of function and proteins in intact and skinned murine diaphragm muscle. Pflugers Arch 440: 727-734.
9. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, Ko JK, Lin P, Thornton A, Zhao X, Pan Z, Komazaki S, Brotto M, Takeshima H, Ma J (2009) MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11: 56-64.
10. Cherian PP, Siller-Jackson AJ, Gu S, Wang X, Bonewald LF, Sprague E, Jiang JX (2005) Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell 16: 3100-3106.
11. Chien KR, Karsenty G (2005) Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 120: 533-544.
12. Daly R, Saxon L, Turner C, Robling A, Bass S (2004) The relationship between muscle size and bone geometry during growth and in response to exercise. Bone 34: 281-287.
13. de Paula Brotto M, van Leyen SA, Brotto LS, Jin JP, Nosek CM, Nosek TM (2001) Hypoxia/fatigue-induced degradation of troponin I and troponin C: new insights into physiologic muscle fatigue. Pflugers Arch 442: 738-744.
14. Elkasrawy MN, Hamrick MW (2010) Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact 10: 56-63.
15. Frost HM (1960) Micropetrosis. J Bone Joint Surg Am 42A: 144-150.
16. Frost HM (1988) Vital biomechanics: proposed general concepts for skeletal adaptations to mechanical usage. Calcif. Tissue Int 42: 145-156.
17. Grossman J, Gordon R, Ranganath V, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62: 1515-1526.
18. Huber C, Collishaw S, Mosley J, Reeve J, Noble BS (2007) Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance. Calcif Tissue Int 81: 139-144.
19. Jia J, Yao W, Guan M, Dai W, Shahnazari M, Kar R, Bonewald LF, Jiang JX, Lane NE (2011) Glucocorticoid dose determines osteocyte cell fate. FASEB J 25: 3366-3376.
20. Jones HH, Priest JD, Hayes WC, Tichenor CC, Nagel DA (1977) Humeral hypertrophy in response to exercise. J Bone Joint Surg Am 59A: 204-208.
21. Kamel M, Picconi J, Lara-Castillo N, Johnson ML (2010) Activation of β-catenin signaling in MLO-Y4 osteocytic cells versus 2T3 osteoblastic cells by fluid flow shear stress and PGE2: Implications for the study of mechanosensation in bone. Bone 47: 872-881.
22. Karasik D, Kiel D (2010) Evidence for pleiotropic factors in genetics of the musculoskeletal system. Bone 46: 1226-1237.
23. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF (1997) Establishment of an osteocyte-like cell line, MLO-Y4. J. Bone Miner Res 12: 2014-2023.
24. Kitase Y, Barragan L, Qing H, Kondoh S, Jiang JX, Johnson ML, Bonewald LF (2010) Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways. J Bone Miner Res 25: 2657-2668.
25. Klein-Nulend J, Bonewald LF (2008) The Osteocyte. In: Principles of Bone Biology (J.P. Bilezikian, L.G. Raisz, J.T. Martin, eds), Academic Press, San Diego, pp 153-174.
26. Klein-Nulend J, van der PA, Semeins CM, Ajubi NE, Frangos JA, Nijweide PJ, Burger EH (1995) Sensitivity of osteocytes to biomechanical stress in vitro. FASEB J 9: 441-445.
27. Kogianni G, Mann V, Noble BS (2008) Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res 23: 915-927.
28. Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, Weber PB, Feng JQ, Bonewald LF, Kneissel M (2010) Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 30: 3071-3085.
29. Kreiner F, Langberg H, Galbo H (2010) Increased muscle interstitial levels of inflammatory cytokines in polymyalgia rheumatica. Arthritis Rheum 62: 3768-3775.
30. Lane NE, Lukert B (1998) The science and therapy of glucocorticoid-induced bone loss. Osteoporosis 27: 465-483.
31. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe D, Harris T (2010) Sarcopenia: etiology, clinical consequences, intervention and assessment. Osteoporos Int 21: 543-559.
32. Lawrence MS, Meyer HR, Matthews NL (1962) Comparative increase in muscle strength in the quadriceps femoris by isometric and isotonic exercise and effects on the contralateral muscle. J Am Phys Ther Assoc 42: 15-20.
33. Leblanc AD, Spector ER, Evans HJ, Sibonga JD (2007) Skeletal responses to space flight and the bed rest analog: a review. J. Musculoskelet Neuronal Interact 7: 33-47.
34. Liu Y, Porta A, Peng X, Gengaro K, Cunningham EB, Li H, Dominguez LA, Bellido T, Christakos S (2004) Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k. J Bone Miner Res 19: 479-490.
35. Noble BS (2003) Bone microdamage and cell apoptosis. Eur Cell Mater 6: 46-55.
36. Noble BS, Stevens H, Loveridge N, Reeve J (1997) Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone 20: 273-282.
37. Noursadeghi M, Tsang J, Haustein T, Miller RF, Chain BM, Katz DR (2008) Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. J Immunol Methods 329: 194-200.
38. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145: 1835-1841.
39. Pedersen BK (2011) Muscles and their myokines. J Exp Biol 214: 337-346.
40. Peterson S, Peterson M, Raymond G, Gilligan C, Checovich M, Smith E (1991) Muscular strength and bone density with weight training in middle-aged women. Med Sci Sports Exerc 23: 499-504.
41. Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 104: 1363-1374.
42. Qiu S, Rao DS, Palnitkar S, Parfitt AM (2002) Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone 31: 313-318.
43. Robinson JA, Chatterjee-Kishore M, Yaworsky PJ, Cullen DM, Zhao W, Li C, Kharode Y, Sauter L, Babij P, Brown E L, Hill AA, Akhter M P, Johnson ML, Recker R R, Komm BS, Bex FJ (2006) Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone. J Biol Chem 281: 31720-31728.
44. Romero-Suarez S, Shen J, Brotto L, Hall T, Mo C, Valdivia HH, Andresen J, Wacker M, Nosek TM, Qu CK, Brotto M (2010) Muscle-specific inositide phosphatase (MIP/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis. Aging 2: 504-513.
45. Shen J, Yu W, Brotto M, Scherman JA, Guo C, Stoddard C, Nosek TM, Valdivia HH, Qu CK (2009) Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol 11: 769-776.
46. Stern AR, Stern MM, Van Dyke ME, Jähn K, Prideaux M, Bonewald LF (2012) Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 52: 361-373.
47. Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, Ito M, Takeshita S, Ikeda K (2007) Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab 5: 464-475.
48. Thornton A, Zhao X, Weisleder N, Brotto LS, Bougoin S, Nosek TM, Reid M, Hardin B, Pan Z, Ma J, Parness J, Brotto M (2011) Store-operated Ca(2+) entry (SOCE) contributes to normal skeletal muscle contractility in young but not in aged skeletal muscle. Aging 3: 621-634.
49. Tomkinson A, Reeve J, Shaw RW, Noble BS (1997) The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Metab 82: 3128-3135.
50. Turner CH (1998) Three rules for bone adaptation to mechanical stimuli. Bone 23: 399-407.
51. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39: 1383-1386.
52. Weinstein RS, Manolagas SC (2000) Apoptosis and osteoporosis. Am J Med 108: 153-164.
53. Weinstein RS, Jilka R, Parfitt A, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282.
54. Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85: 2907-2912.
55. Weisleder N, Brotto M, Komazaki S, Pan Z, Zhao X, Nosek T, Parness J, Takeshima H, Ma J (2006) Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J Cell Biol 174: 639-645.
56. Wolff J (1892) Das gesetz der transformation der knochen. Verlag von August Hirschwald, Berlin. [Translated by Maquet P, Furlong R (1986) The law of bone remodelling. Springer-Verlag, Berlin, pp 3-22.]
57. Wong SY, Kariks J, Evans RA, Dunstan CR, Hills E (1985) The effect of age on bone composition and viability in the femoral head. J. Bone Joint Surg Am 67A: 274-283.
58. Xia X, Kar R, Gluhak-Heinrich J, Yao W, Lane NE, Bonewald LF, Biswas SK, Lo WK, Jiang JX (2010a) Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res 25: 2479-2488.
59. Xia X, Batra N, Shi Q, Bonewald L, Sprague E, Jiang J (2010b) Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling. Mol Cell Biol 30: 206-219.
60. Zhao S, Zhang YK, Harris S, Ahuja SS, Bonewald LF (2002) MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res 17: 2068-2079.
61. Zhao X, Weisleder N, Thornton A, Thornton A, Oppong Y, Campbell R, Ma J, Brotto M (2008) Compromised store-operated Ca2+ entry in aged skeletal muscle. Aging Cell 7: 561-568.
62. Brotto MA, Nagaraj RY, Brotto LS, Takeshima H, Ma JJ, Nosek TM (2004) Defective maintenance of intracellular Ca2+ homeostasis is linked to increased muscle fatigability in the MG29 null mice. Cell Res 14: 373-378.
63. Naparus A, Ashrafpour H, Huang N, Hofer SO, Zhong T, Forrest CR, Pang CY (2012) Combination of hypoxic preconditioning and postconditioning does not induce additive protection of ex vivo human skeletal muscle from hypoxia/reoxygenation injury. J Cardiovasc Pharmacol [Epub ahead of print, PMID:22691884].
64. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev, 88:1379-1406.
65. Scheele C, Nielsen S, Pedersen BK (2009) ROS and myokines promote muscle adaptation to exercise. Trends Endocrinol Metab., 20:95-99.
66. Warren GL, Hayes DA, Lowe DA, Williams JH, Armstrong RB (1994) Eccentric contraction-induced injury in normal and hindlimb-suspended mouse soleus and EDL muscles. J Appl Physiol 77: 1421-1430.